1[1]Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory [J]. Clin Microbiol Rev, 1993; 6(4) ∶ 428 被引量：1
2[2]Polk HC Jr, Christmas AB. Prophylactic antibiotics in surgery and surgical wound infections [J]. Am Surg, 2000; 66(2) ∶ 105 被引量：1
3[3]Haley RW, Culver DH, Morgan WM, et al. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination [J]. Am J Epidemiol, 1985; 121(2) ∶ 206 被引量：1
4[4]Novelli A. Antimicrobial prophylaxis in surgery: the role of pharmacokinetics [J]. J Chemother, 1999; 11(6) ∶ 565 被引量：1
5[5]Esposito S. Is single-dose antibiotic prophylaxis sufficient for any surgical procedure? [J]. J Chemother, 1999; 11(6) ∶ 556 被引量：1
6[6]Scher KS. Studies on the duration of antibiotic administration for surgical prophylaxis [J]. Am Surg, 1997; 63(1) ∶ 59 被引量：1
7[7]Fabian TC, Croce MA, Payne LW, et al. Duration of antibiotic therapy for penetrating abdominal trauma: a prospective trial [J].Surgery, 1992; 112(4) ∶ 788 被引量：1
8[1]Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med, 2001, 134:479～486. 被引量：1
9[2]Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med, 2001,34: 487 ～ 489. 被引量：1
10[3]Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med, 2001, 134:490～494. 被引量：1
3Academy of Managed Carc Pharmacy. The Academy of managed care pharmacy's concepts in managed care pharmacy[J]. Drug Use Evaluation. 1997. 被引量：1
4W. Thames, B. Yao, Scheifele, et al. Drug Use Evaluation of darbepoetin Alfa in Anemic Patients Undergoing Chemotherapy Supports a Fixed Dose of 200ug Given Every 2 Weeks[J]. The Journal of Supportive Oncology,2003,1 (9) : 14. 被引量：1
5Jae P. Bae. Evaluation of Drug Use Review Demonstration Projects, Project Officer Health Care Financing Administration Office of Research and Demonstrations, HCFA Evaluation of Drug Review Projects Final report, 1998: 1- 376. 被引量：1
6American Society of Hospital Pharmacists. ASHP Guidelines on Medication-use Evaluation, Formulary Management Guidelines. 1996,;53:117- 119. 被引量：1
7Alan Lyles, llene H Zuckerman, Susan M Dc Sipio, et al. When warnings are not enough: Primary prevention through drug use review to avoid adverse drug interactions, clinical data should follow lhe patient in the same way that financial data do [J]. Health Affairs, 1998,17(5) : 175-183. 被引量：1
8Catherine C. Peng, Peter A. Glassman, Inyr. Marks, et al. Retrospective Drug Utilization Review: Incidence of Clinically Relevant Potential Drug Drug Interactions in a Large Ambulatory Population[J]. Journal of Managed Care Pharmacy,2003, 9(6):513- 522. 被引量：1
